The Acute Stroke or Transient Ischemic Attack Treated with Ticagrelor and Aspirin for Prevention of Stroke and Death (THALES) trial: Rationale and design

RATIONALE: In patients with acute cerebral ischemia, the rate of stroke, myocardial infarction, or death during 90 days was reported to be non-significantly lower with ticagrelor compared with aspirin, with no increase in major hemorrhage. Dual antiplatelet therapy may be more effective in this sett...

Descripción completa

Detalles Bibliográficos
Autores principales: Johnston, S Claiborne, Amarenco, Pierre, Denison, Hans, Evans, Scott R, Himmelmann, Anders, James, Stefan, Knutsson, Mikael, Ladenvall, Per, Molina, Carlos A, Wang, Yongjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6826854/
https://www.ncbi.nlm.nih.gov/pubmed/30747613
http://dx.doi.org/10.1177/1747493019830307